𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Physicochemical purification and immunological characteristics of ductal carcinoma antigen

✍ Scribed by Lawrence D. Papsidero; Edward A. Johnson


Publisher
John Wiley and Sons
Year
1986
Tongue
French
Weight
742 KB
Volume
37
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Ductal carcinoma antigen (DCA), as recognized by monoclonal antibody (MAb) F36122, was purified in high yield and to homogeneity from malignant effusions by means of physicochemical techniques. Fractionation procedures were monitored by immunoenzymometric assays. Preparations purified over 2,000-fold were obtained through acid-extraction, lectin-chromatographies and gel filtration steps. Purified antigen demonstrated a single component upon electrophoretic examination. This material had a high molecular weight and high immunoreactivity. Neuraminidase treatments failed to perturb the antigenicity of the component, indicating an absence of sialic acid residues at the antibody-combining site. Further, extensive proteolytic digestion effected the release of heterogeneous glycopeptides which retained immunologic activity, suggesting the presence of carbohydrate at the active site. Immunologically, DCA was compared with other tumor-associated mucin-like glycoproteins which have been detected in the circulation of patients. Results indicated no cross-reactivity between DCA and other mucins, including CA 19-9 and CA-125. Further, no antigenic relationship was noted for purified carcinoembryonic antigen (CEA), also a heavilyplycosylated structure. These data thus suggest that immunological monitoring of disease may be approached using a selected panel of antigenically distinct reagents.

'To whom reprint requests should be sent, at Cellular Products, Inc.


πŸ“œ SIMILAR VOLUMES


Comparison of enhancement characteristic
✍ Ritse M. Mann; Jeroen Veltman; Henkjan Huisman; Carla Boetes πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 202 KB

## Abstract ## Purpose: To compare enhancement characteristics between invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) on contrast enhanced MRI of the breast and to observe the magnitude of eventual differences as these may impair the diagnostic value of breast MRI in ILC. ##

A subset of breast invasive ductal carci
✍ Lu, Di ;Masood, Shahla ;Khalbuss, Walid E. ;Bui, Marilyn πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 968 KB

## Background: Invasive ductal carcinoma of the breast is a heterogeneous collection of divergent types of carcinomas. some subtypes have been characterized by histologic observations. this study describes a distinctive subset recognized through cytomorphologic examination of breast carcinoma speci

Purification of herpes simplex virus tum
✍ Roberta Cocchiara; Prof. Giulio Tarro; Giovanni Flaminio; Mario Di Gioia; Riccar πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 789 KB

In the present study, we attempted to purify herpes simplex virus (HSV) tumor associated antigen(s) (TAA) extracted from human kidney carcinoma. Trypsinized human tumor cells were sonicated for 9 minutes and clarified at 100,000 x g for 1 hour; the supernate yielded 70% of detectable TAA as determin

Biochemical and immunological properties
✍ Maria Prat; Enzo Medico; Cristina Garrino; Paolo M. Comoglio πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 French βš– 979 KB

The monoclonal antibody (MAb) BD-5 reacts with an epitope (CAR-5) expressed in 83% of the gastric carcinomas and in 51% of the ductal pancreatic carcinomas. This MAb reacts also with epithelial cells of colorectal mucosa, but does not react at all with normal adult gastric mucosa or normal adult pan

Analysis of production, purification, an
✍ Hedda H. van Ravenswaay Claasen; RenΓ© J. van de Griend; Delia Mezzanzanica; Rein πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 French βš– 993 KB

## Abstract OV‐TL 3 and MOvl8 MAbs, due to their restricted specificity, have been successfully used to visualize ovarian cancer in patients and might therefore be used to develop therapies for ovarian cancer. The bi‐specific MAbs Ξ±T3/OC2 and Ξ±OC/TR (both being combinations of MOvl8 and aCD3) have